Medtronic trial site draws FDA ire; OmniVision more than doubles revenue, income;

 @FierceMedDev: Boston Scientific posts positive Watchman data. Item | Follow @FierceMedDev

 @MarkHFierce: Fledgling Dx company GeneCentric is raising money to support a lung cancer Dx commercial launch. More | Follow @MarkHFierce

 @DamianFierce: More worry for Intuitive Surgical as the FDA gets involved in the scrutiny of da Vinci robots. Story | Follow @DamianFierce

> One of the study sites for Medtronic's ($MDT) CoreValve pivotal trial has received an FDA warning letter, but Medtronic says the problems cited don't affect the data gathered on the device. Article

> Imaging device company OmniVision ($OVTI) pulled in revenue of $423.5 million last quarter, an increase of about 128% over the previous, and the company more than doubled its net income to $21.3 million. Results

> Zimmer ($ZMH) says federal investigators have closed their probe of the company's Asian operation. Story

> ArthroCare ($ARTC) picked up FDA clearance for the SpeedLock HIP Knotless Fixation implant, designed to help surgeons reattach soft tissue to bone in hip procedures. News

> Touch Medical Solutions, a division of DMH International ($DMHI), won FDA approval for its medical imaging software suite, TouchPACS, considered a Class II device by the agency. Item

> Wisconsin startup Swallow Solutions has raised just over $1 million in Series A financing to commercialize its novel dysphagia treatment platform, designed to treat patients with difficulty swallowing. More

Biotech News

 @FierceBiotech: From : GSK jumps new IT hurdles in 'real-world' test of blockbuster hopeful. Editor's Corner | Follow @FierceBiotech

@JohnCFierce: Lundbeck gets EU nod for new drug to fight alcohol addiction--$300M tops; no U.S. plans. Story | Follow @JohnCFierce

@RyanMFierce: Alere grabbed some Gates Foundation funding for Tuberculosis and HIV testing products. Release | Follow @RyanMFierce

> As sequestration dawns, FDA supporters scramble to ease woes on drug reviews. Report

> Facebook, Google geeks 'hack' into cancer research problem with mobile game. More

> FDA pins approval on once-monthly version of blockbuster Abilify. Article

Pharma News

@FiercePharma: Merck's Tredaptive fiasco blamed on adverse reactions to niacin. Article | Follow @FiercePharma

@EricPFierce: Must be some folks sorry Mylan got Agila and they didin't. Hikma says it is getting interest in its injectables biz. Story | Follow @EricPFierce

> Roche dropping Herceptin price in India by 30%. Report

> Lundbeck, Otsuka's new Abilify Maintena to face entrenched rivals. More

> Fewer generics approved in 2012 but still a banner year. Story

Suggested Articles

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.

The former CEO of the molecular testing company Foundation Medicine, Troy Cox, has been named chairman of the Swiss big data firm Sophia Genetics.

Researchers at MIT used a machine-learning algorithm to uncover the potent antibiotic properties hiding within an old small-molecule candidate.